Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Sell
5,725
-673
-11% -$36.5K 0.12% 75
2025
Q4
$314K Sell
6,398
-39
-0.6% -$1.82K 0.12% 78
2025
Q3
$278K Buy
+6,437
New +$251K 0.11% 84
2025
Q2
Sell
-9,836
Closed -$381K 83
2025
Q1
$381K Sell
9,836
-1,443
-13% -$52.8K 0.18% 67
2024
Q4
$381K Buy
+11,279
New +$406K 0.17% 71

Other funds holding GSK

Potentia Wealth's GSK Position: Q1 2026 in Review

Potentia Wealth reduced its GSK (GSK) stake by 11% in Q1 2026, selling an estimated $36.5K and leaving 5,725 shares worth $316K. The position accounts for 0.12% of the portfolio, ranked #75.

Potentia Wealth first reported a position in GSK in Q4 2024 and has held it in 5 quarters since. The position peaked at $381K in Q4 2024. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Potentia Wealth held 5,725 shares of GSK worth $316K as of Q1 2026.
  • Potentia Wealth sold 673 GSK shares in Q1 2026, an estimated $36.5K.
  • GSK made up 0.12% of Potentia Wealth's portfolio in Q1 2026, its #75 holding.
  • Potentia Wealth first reported a position in GSK in Q4 2024 and has held it in 5 quarters since.
  • Potentia Wealth's GSK position peaked at $381K in Q4 2024.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Potentia Wealth's 13F filing for Q1 2026, filed 11 May 2026.